Cargando…

Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration

BACKGROUND: The prevalence and clinical profile of asthma with airflow obstruction (AO) remain uncertain. We aimed to phenotype AO in population- and clinic-based cohorts. METHODS: This cross-sectional multicohort study included adults ≥50 years from nine CADSET cohorts with spirometry data (N=69 78...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertels, Xander, Edris, Ahmed, Garcia-Aymerich, Judith, Faner, Rosa, Meteran, Howraman, Sigsgaard, Torben, Alter, Peter, Vogelmeier, Claus, Olvera, Nuria, Kermani, Nazanin Zounemat, Agusti, Alvar, Donaldson, Gavin C, Wedzicha, Jadwiga A, Brusselle, Guy G, Backman, Helena, Rönmark, Eva, Lindberg, Anne, Vonk, Judith M, Chung, Kian Fan, Adcock, Ian M, van den Berge, Maarten, Lahousse, Lies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450061/
https://www.ncbi.nlm.nih.gov/pubmed/37612099
http://dx.doi.org/10.1136/bmjresp-2023-001760
_version_ 1785095112000274432
author Bertels, Xander
Edris, Ahmed
Garcia-Aymerich, Judith
Faner, Rosa
Meteran, Howraman
Sigsgaard, Torben
Alter, Peter
Vogelmeier, Claus
Olvera, Nuria
Kermani, Nazanin Zounemat
Agusti, Alvar
Donaldson, Gavin C
Wedzicha, Jadwiga A
Brusselle, Guy G
Backman, Helena
Rönmark, Eva
Lindberg, Anne
Vonk, Judith M
Chung, Kian Fan
Adcock, Ian M
van den Berge, Maarten
Lahousse, Lies
author_facet Bertels, Xander
Edris, Ahmed
Garcia-Aymerich, Judith
Faner, Rosa
Meteran, Howraman
Sigsgaard, Torben
Alter, Peter
Vogelmeier, Claus
Olvera, Nuria
Kermani, Nazanin Zounemat
Agusti, Alvar
Donaldson, Gavin C
Wedzicha, Jadwiga A
Brusselle, Guy G
Backman, Helena
Rönmark, Eva
Lindberg, Anne
Vonk, Judith M
Chung, Kian Fan
Adcock, Ian M
van den Berge, Maarten
Lahousse, Lies
author_sort Bertels, Xander
collection PubMed
description BACKGROUND: The prevalence and clinical profile of asthma with airflow obstruction (AO) remain uncertain. We aimed to phenotype AO in population- and clinic-based cohorts. METHODS: This cross-sectional multicohort study included adults ≥50 years from nine CADSET cohorts with spirometry data (N=69 789). AO was defined as ever diagnosed asthma with pre-BD or post-BD FEV(1)/FVC <0.7 in population-based and clinic-based cohorts, respectively. Clinical characteristics and comorbidities of AO were compared with asthma without airflow obstruction (asthma-only) and chronic obstructive pulmonary disease (COPD) without asthma history (COPD-only). ORs for comorbidities adjusted for age, sex, smoking status and body mass index (BMI) were meta-analysed using a random effects model. RESULTS: The prevalence of AO was 2.1% (95% CI 2.0% to 2.2%) in population-based, 21.1% (95% CI 18.6% to 23.8%) in asthma-based and 16.9% (95% CI 15.8% to 17.9%) in COPD-based cohorts. AO patients had more often clinically relevant dyspnoea (modified Medical Research Council score ≥2) than asthma-only (+14.4 and +14.7 percentage points) and COPD-only (+24.0 and +5.0 percentage points) in population-based and clinic-based cohorts, respectively. AO patients had more often elevated blood eosinophil counts (>300 cells/µL), although only significant in population-based cohorts. Compared with asthma-only, AO patients were more often men, current smokers, with a lower BMI, had less often obesity and had more often chronic bronchitis. Compared with COPD-only, AO patients were younger, less often current smokers and had less pack-years. In the general population, AO patients had a higher risk of coronary artery disease than asthma-only and COPD-only (OR=2.09 (95% CI 1.26 to 3.47) and OR=1.89 (95% CI 1.10 to 3.24), respectively) and of depression (OR=1.41 (95% CI 1.19 to 1.67)), osteoporosis (OR=2.30 (95% CI 1.43 to 3.72)) and gastro-oesophageal reflux disease (OR=1.68 (95% CI 1.06 to 2.68)) than COPD-only, independent of age, sex, smoking status and BMI. CONCLUSIONS: AO is a relatively prevalent respiratory phenotype associated with more dyspnoea and a higher risk of coronary artery disease and elevated blood eosinophil counts in the general population compared with both asthma-only and COPD-only.
format Online
Article
Text
id pubmed-10450061
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-104500612023-08-26 Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration Bertels, Xander Edris, Ahmed Garcia-Aymerich, Judith Faner, Rosa Meteran, Howraman Sigsgaard, Torben Alter, Peter Vogelmeier, Claus Olvera, Nuria Kermani, Nazanin Zounemat Agusti, Alvar Donaldson, Gavin C Wedzicha, Jadwiga A Brusselle, Guy G Backman, Helena Rönmark, Eva Lindberg, Anne Vonk, Judith M Chung, Kian Fan Adcock, Ian M van den Berge, Maarten Lahousse, Lies BMJ Open Respir Res Asthma BACKGROUND: The prevalence and clinical profile of asthma with airflow obstruction (AO) remain uncertain. We aimed to phenotype AO in population- and clinic-based cohorts. METHODS: This cross-sectional multicohort study included adults ≥50 years from nine CADSET cohorts with spirometry data (N=69 789). AO was defined as ever diagnosed asthma with pre-BD or post-BD FEV(1)/FVC <0.7 in population-based and clinic-based cohorts, respectively. Clinical characteristics and comorbidities of AO were compared with asthma without airflow obstruction (asthma-only) and chronic obstructive pulmonary disease (COPD) without asthma history (COPD-only). ORs for comorbidities adjusted for age, sex, smoking status and body mass index (BMI) were meta-analysed using a random effects model. RESULTS: The prevalence of AO was 2.1% (95% CI 2.0% to 2.2%) in population-based, 21.1% (95% CI 18.6% to 23.8%) in asthma-based and 16.9% (95% CI 15.8% to 17.9%) in COPD-based cohorts. AO patients had more often clinically relevant dyspnoea (modified Medical Research Council score ≥2) than asthma-only (+14.4 and +14.7 percentage points) and COPD-only (+24.0 and +5.0 percentage points) in population-based and clinic-based cohorts, respectively. AO patients had more often elevated blood eosinophil counts (>300 cells/µL), although only significant in population-based cohorts. Compared with asthma-only, AO patients were more often men, current smokers, with a lower BMI, had less often obesity and had more often chronic bronchitis. Compared with COPD-only, AO patients were younger, less often current smokers and had less pack-years. In the general population, AO patients had a higher risk of coronary artery disease than asthma-only and COPD-only (OR=2.09 (95% CI 1.26 to 3.47) and OR=1.89 (95% CI 1.10 to 3.24), respectively) and of depression (OR=1.41 (95% CI 1.19 to 1.67)), osteoporosis (OR=2.30 (95% CI 1.43 to 3.72)) and gastro-oesophageal reflux disease (OR=1.68 (95% CI 1.06 to 2.68)) than COPD-only, independent of age, sex, smoking status and BMI. CONCLUSIONS: AO is a relatively prevalent respiratory phenotype associated with more dyspnoea and a higher risk of coronary artery disease and elevated blood eosinophil counts in the general population compared with both asthma-only and COPD-only. BMJ Publishing Group 2023-08-23 /pmc/articles/PMC10450061/ /pubmed/37612099 http://dx.doi.org/10.1136/bmjresp-2023-001760 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Asthma
Bertels, Xander
Edris, Ahmed
Garcia-Aymerich, Judith
Faner, Rosa
Meteran, Howraman
Sigsgaard, Torben
Alter, Peter
Vogelmeier, Claus
Olvera, Nuria
Kermani, Nazanin Zounemat
Agusti, Alvar
Donaldson, Gavin C
Wedzicha, Jadwiga A
Brusselle, Guy G
Backman, Helena
Rönmark, Eva
Lindberg, Anne
Vonk, Judith M
Chung, Kian Fan
Adcock, Ian M
van den Berge, Maarten
Lahousse, Lies
Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration
title Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration
title_full Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration
title_fullStr Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration
title_full_unstemmed Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration
title_short Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration
title_sort phenotyping asthma with airflow obstruction in middle-aged and older adults: a cadset clinical research collaboration
topic Asthma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450061/
https://www.ncbi.nlm.nih.gov/pubmed/37612099
http://dx.doi.org/10.1136/bmjresp-2023-001760
work_keys_str_mv AT bertelsxander phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT edrisahmed phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT garciaaymerichjudith phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT fanerrosa phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT meteranhowraman phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT sigsgaardtorben phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT alterpeter phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT vogelmeierclaus phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT olveranuria phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT kermaninazaninzounemat phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT agustialvar phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT donaldsongavinc phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT wedzichajadwigaa phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT brusselleguyg phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT backmanhelena phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT ronmarkeva phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT lindberganne phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT vonkjudithm phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT chungkianfan phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT adcockianm phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT vandenbergemaarten phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration
AT lahousselies phenotypingasthmawithairflowobstructioninmiddleagedandolderadultsacadsetclinicalresearchcollaboration